Listed

GENERAL ATLANTIC, L.P.

An institutional investment manager in New York, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1017645.

Share

Holdings: 12 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

GENERAL ATLANTIC, L.P., holdings
IssuerClassCUSIPReported value$mWeightSharesPut or callChange on the quarter before
Liftoff MobileLFTOCOM53229X10160820.9%25,315,646New+25,315,646
DlocalCL AG2901810160620.9%46,656,695Unchanged
ChimeCHYMCOM SHS CL A16935C10943515.0%21,259,683Unchanged
AlkamiALKTCOM01644J10835112.1%19,379,038Added+4,041,543
XP, IncCL AG9823910933411.5%20,566,133Unchanged
PharvarisCOMN696051082277.8%6,550,757Reduced−1,480,495
Seaport TherapeuticsSPTXCOM81221K1081334.6%6,101,582New+6,101,582
Nurix TherapeuticsNRIXCOM67080M10373.62.5%3,032,185Reduced−1,069,680
Revolution MedicinesRVMDCOM76155X10067.02.3%357,791Reduced−350,000
Parabilis MedicinesPBLSCOM69895510142.11.4%1,538,461New+1,538,461
RiskifiedCL AM8216R10926.80.9%5,324,998Unchanged
Grove CollaborativeGROVCL A39957D2013.10.1%2,474,859Unchanged

Sold out: 3 positions

Held at the end of the quarter before and not reported this quarter.

GENERAL ATLANTIC, L.P., positions sold out
IssuerClassCUSIPReported value$WeightSharesPut or callChange on the quarter before
Centessa PharmaceuticalsADS1523091000.00.0%0Sold out−1,354,830
European Wax CenterCL A29882P1060.00.0%0Sold out−13,110,492
WebullORD SHSG9572D1030.00.0%0Sold out−50,816

Source: SEC EDGAR, Form 13F-HR, accession 0000950142-26-002338 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.